Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Clinical trial NCT03937635 · RECRUITING
Trial details
- NCT number
- NCT03937635
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-16
- Primary completion
- 2029-12-31
- Enrollment
- 288
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.